Skip to content

Comparison of Ultrasound-guided versus the Anatomical Landmark technique for Central Venous Cannulation of the Subclavian Vein

Comparison of Real-time Ultrasound-guided versus the Anatomical Landmark technique for Central Venous Cannulation of the Subclavian Vein via Infraclavicular approach

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014775
Enrollment
50
Registered
2018-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: null- Patients presenting to OT and ICU with routine indication for central venous cannulation

Interventions

Intervention1: Real-time ultrasound technique: An Ultrasound machine equipped with a high-resolution 5 -10 MHz transducer with linear probe for vascular access will be used. The transducer will be cov

Sponsors

Armed Forces Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Routine indication to be present for central venous cannulation Patients who are sedated and mechanically ventilated in OT and ICU

Exclusion criteria

Exclusion criteria: Prior Subclavian Central Venous Cannulation Coagulation disorders Infection at insertion site

Design outcomes

Primary

MeasureTime frame
To determine the rate of success and incidence of mechanical complications with real-time ultrasound guided subclavian vein central venous cannulation and the landmark techniqueTimepoint: During Procedure

Secondary

MeasureTime frame
To determine if real-time ultrasound guided technique for subclavian central venous cannulation can be incorporated into the present Standard Operating Procedures.Timepoint: During Procedure

Countries

India

Contacts

Public ContactKiran S

AFMC, Pune

drkirans@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026